Ali Ghasemi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ali Ghasemi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amin Rezaei
Shiraz University of Medical Sciences
1 shared publication- Elahe Ghayebie Motlagh
Student Research Committee, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Elham Bakhtiari
Clinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Fateme Borzoee
Non-Communicable Diseases Research Center, Department of Operating Room, School of Paramedics, Sabzevar University of Medical Sciences, Sabzevar, Iran
1 shared publication - Hossein Karimi Moonaghi
Nursing and Midwifery Care Research Center and Medical Sciences Education Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Mahmoud Bakhshi
Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- Open Access
- 18 September 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (6) , 292-297
Pulmonary Invasive Fungal Disease: Ultrasound and Computed Tomography Scan Findings
Diagnostic methods,pediatric lung disease,respiratory infections,invasive fungal disease
- 18 September 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (6) , 292-297
Open AccessPulmonary Invasive Fungal Disease: Ultrasound and Computed Tomography Scan Findings
Diagnostic methods,pediatric lung disease,respiratory infections,invasive fungal disease
- Open Access
- 4 December 2022
- Published by Maad Rayan Publishing Company in Journal of Caring Sciences
- Vol. 12 (1) , 64-72
The Conflict between the Beliefs of the Health Care Providers and Family Caregivers in the Use of Traditional Medicine in Pediatric Oncology: An Ethnographic Study
Introduction: Traditional medicine are popular treatments among families of children with cancer. This study was designed to identify the behaviors, beliefs, and values of families and health care providers for the use of traditional medicine in pediatric oncology. Methods: This study was conducted with a focus on ethnography approach in the oncology department of a pediatric subspecialty hospital in northeastern of Iran from September 2021 to June 2022. A total of 20 key informants were observed and interviewed formally and informally. The Miles and Huberman (1994) approach was used for data analysis. Results: Finally, two main cultural themes were emerged, including the blame of traditional herbal medicine and the synergy of rituals with modern therapies. Families use traditional medicine based on values passed down from generation to generation, while health care providers make evidence-based decisions. Conclusion: The results of the present study represent the conflict between health care providers and families in the use of medicinal herbs. The findings allow care providers to be aware of the beliefs and values of children caregivers to make the right decision about traditional medicine use.
- 4 December 2022
- Published by Maad Rayan Publishing Company in Journal of Caring Sciences
- Vol. 12 (1) , 64-72
Open AccessThe Conflict between the Beliefs of the Health Care Providers and Family Caregivers in the Use of Traditional Medicine in Pediatric Oncology: An Ethnographic Study
Introduction: Traditional medicine are popular treatments among families of children with cancer. This study was designed to identify the behaviors, beliefs, and values of families and health care providers for the use of traditional medicine in pediatric oncology. Methods: This study was conducted with a focus on ethnography approach in the oncology department of a pediatric subspecialty hospital in northeastern of Iran from September 2021 to June 2022. A total of 20 key informants were observed and interviewed formally and informally. The Miles and Huberman (1994) approach was used for data analysis. Results: Finally, two main cultural themes were emerged, including the blame of traditional herbal medicine and the synergy of rituals with modern therapies. Families use traditional medicine based on values passed down from generation to generation, while health care providers make evidence-based decisions. Conclusion: The results of the present study represent the conflict between health care providers and families in the use of medicinal herbs. The findings allow care providers to be aware of the beliefs and values of children caregivers to make the right decision about traditional medicine use.
- 12 March 2015
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 46 (2) , 138-142
Determination of Urinary 5-Hydroxyindoleacetic Acid as a Metabolomics in Gastric Cancer
The aim of this paper is to study urinary5-hydroxyindoleacetic acid (5-HIAA) in gastric cancer patients with a biochemical method and compare this metabolite with normal control and individuals with chronic gastritis. The subjects were 48 histologically proven gastric adenocarcinoma patients. They were 10 women and 38 men with mean age of 63.73 years. For determination of urinary excretion of 5-HIAA, a biochemical method was applied. According to kit protocol, the patients’ fresh urine was added to the reagent material, and the color of the sediment that was the result of interaction between 5-HIAA and the mercury salt was compared with the standard colorimetric plate of the kit. The same method was also performed for a group of 47 patients with chronic gastritis and also a group of 50 normal individuals (age and sex matched). Urinary 5-HIAA was significantly higher in gastric cancer patients compared to individuals with chronic gastritis and normal controls (P value <0.001), but no association was detected in urinary 5-HIAA based on age, sex, or site of tumor and tumor grade in gastric cancer patients group. Also, no significant difference was noted in 5-HIAA excretion between chronic gastritis and normal control groups. Urinary excretion of 5-HIAA is significantly higher in the gastric cancer patients in comparison with that of chronic gastritis patients or normal individuals. So, this test could be regarded as a tumor marker in conjunction with other modalities in diagnosis of gastric cancer.
- 12 March 2015
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 46 (2) , 138-142
Determination of Urinary 5-Hydroxyindoleacetic Acid as a Metabolomics in Gastric Cancer
The aim of this paper is to study urinary5-hydroxyindoleacetic acid (5-HIAA) in gastric cancer patients with a biochemical method and compare this metabolite with normal control and individuals with chronic gastritis. The subjects were 48 histologically proven gastric adenocarcinoma patients. They were 10 women and 38 men with mean age of 63.73 years. For determination of urinary excretion of 5-HIAA, a biochemical method was applied. According to kit protocol, the patients’ fresh urine was added to the reagent material, and the color of the sediment that was the result of interaction between 5-HIAA and the mercury salt was compared with the standard colorimetric plate of the kit. The same method was also performed for a group of 47 patients with chronic gastritis and also a group of 50 normal individuals (age and sex matched). Urinary 5-HIAA was significantly higher in gastric cancer patients compared to individuals with chronic gastritis and normal controls (P value <0.001), but no association was detected in urinary 5-HIAA based on age, sex, or site of tumor and tumor grade in gastric cancer patients group. Also, no significant difference was noted in 5-HIAA excretion between chronic gastritis and normal control groups. Urinary excretion of 5-HIAA is significantly higher in the gastric cancer patients in comparison with that of chronic gastritis patients or normal individuals. So, this test could be regarded as a tumor marker in conjunction with other modalities in diagnosis of gastric cancer.